Related Experiment Video
Updated: Feb 4, 2026

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
miR‑127 aggravates myocardial failure by promoting the TGF‑β1/Smad3 signaling
1Department of Cardiovascular Internal Medicine, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.
Abstract:
Myocardial failure has a negative impact on the quality of human life. MicroRNA (miR) expression abnormalities lead to the development of many pathological conditions, including myocardial failure, and therefore the present study primarily focused on the investigation of the functions of miR‑127 in the development of myocardial failure. The miR‑127 expression levels in serum samples from patients with myocardial failure were examined. Oil red O staining was used to analyze the characteristics of the myocardium of the patients. Immunohistochemistry was used to detect fatty acid synthase (FASN), stearoyl‑CoA desaturase‑1 (SCD1) and mitochondrial brown fat uncoupling protein 1 (UCP1) protein expression in the myocardium of the patients. Furthermore, C57BL/6J (B6) mice were induced with 15 mg/kg of doxorubicin. Echocardiography was used to detect the histopathological alterations of the myocardial cells by comparison of the myocardial tissues from the myocardial failure animal model and normal C57BL/6 mice. Reverse transcription‑quantitative polymerase chain reaction was used to detect the expression levels of miR‑127 following different induction periods and immunohistochemistry was used to detect the expression of transforming growth factor‑β1 (TGF‑β1) and mothers against decapentaplegic homolog 3 (Smad3). Immunofluorescence was used to detect the expression alterations TGF‑β1/Smad3 when miR‑127 overexpression or inhibition was established. The results of the present study indicated that myocardial failure resulted in an upregulated expression of miR‑127 and severe fat accumulation. FASN, SCD1 and UCP1 were highly expressed in the myocardial failure group compared with the control. Abdominal artery contraction and the ejection fraction were significantly reduced in the DOX‑induced B6 mice. The cardiomyocytes became hypertrophic, and left ventricular systolic pressure and left ventricular maximum ejection pressure were altered following DOX induction in B6 mice. The results confirmed that miR‑127 regulates the expression of TGF‑β1/Smad3. The potential pathological mechanism of the effect of miR‑127 may be based on the upregulation of the TGF‑β1/Smad3 signaling pathway.
Insights
MicroRNA-127 (miR-127) is upregulated in myocardial failure, promoting fat accumulation and cardiac dysfunction by activating the TGF-β1/Smad3 pathway.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Myocardial failure significantly impairs quality of life.
- Abnormal microRNA (miR) expression is implicated in myocardial failure pathogenesis.
- Investigating the role of specific miRs, like miR-127, is crucial for understanding and treating this condition.
Purpose of the Study:
- To investigate the function of miR-127 in the development of myocardial failure.
- To examine miR-127 expression levels in patients with myocardial failure.
- To elucidate the molecular mechanisms underlying miR-127's role in cardiac pathology.
Main Methods:
- Serum miR-127 levels were analyzed in patients.
- Oil red O staining and immunohistochemistry assessed myocardial characteristics and protein expression (FASN, SCD1, UCP1).
- A doxorubicin-induced mouse model evaluated cardiac function (echocardiography) and molecular changes (miR-127, TGF-β1, Smad3 expression via RT-qPCR, immunohistochemistry, immunofluorescence).
Main Results:
- Myocardial failure was associated with upregulated miR-127 and significant fat accumulation in the myocardium.
- Key proteins involved in lipid metabolism (FASN, SCD1) and thermogenesis (UCP1) were highly expressed.
- Doxorubicin-induced mice exhibited reduced cardiac function, including decreased ejection fraction and altered ventricular pressures, alongside cardiomyocyte hypertrophy.
- miR-127 was confirmed to regulate the expression of transforming growth factor-β1 (TGF-β1) and mothers against decapentaplegic homolog 3 (Smad3).
Conclusions:
- Upregulated miR-127 contributes to myocardial failure by promoting cardiac fat accumulation and dysfunction.
- The pathological mechanism involves the upregulation of the TGF-β1/Smad3 signaling pathway mediated by miR-127.
- Targeting miR-127 may offer a therapeutic strategy for myocardial failure.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Yeast Signaling
Anaphase Promoting Complex
Pathophysiology of Heart Failure

